Effects of Rifaximin in Patients With Acute Alcoholic Hepatitis
Clinical trial NCT02116556 · UNKNOWN
Trial details
- NCT number
- NCT02116556
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-12-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.